Literature DB >> 18316026

The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.

Paul J Schmidt1, Paul T Toran, Anthony M Giannetti, Pamela J Bjorkman, Nancy C Andrews.   

Abstract

Hemochromatosis is caused by mutations in HFE, a protein that competes with transferrin (TF) for binding to transferrin receptor 1 (TFR1). We developed mutant mouse strains to gain insight into the role of the Hfe/Tfr1 complex in regulating iron homeostasis. We introduced mutations into a ubiquitously expressed Tfr1 transgene or the endogenous Tfr1 locus to promote or prevent the Hfe/Tfr1 interaction. Under conditions favoring a constitutive Hfe/Tfr1 interaction, mice developed iron overload attributable to inappropriately low expression of the hormone hepcidin. In contrast, mice carrying a mutation that interferes with the Hfe/Tfr1 interaction developed iron deficiency associated with inappropriately high hepcidin expression. High-level expression of a liver-specific Hfe transgene in Hfe-/- mice was also associated with increased hepcidin production and iron deficiency. Together, these models suggest that Hfe induces hepcidin expression when it is not in complex with Tfr1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316026      PMCID: PMC2292811          DOI: 10.1016/j.cmet.2007.11.016

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites.

Authors:  A P West; A M Giannetti; A B Herr; M J Bennett; J S Nangiana; J R Pierce; L P Weiner; P M Snow; P J Bjorkman
Journal:  J Mol Biol       Date:  2001-10-19       Impact factor: 5.469

2.  Genes that modify the hemochromatosis phenotype in mice.

Authors:  J E Levy; L K Montross; N C Andrews
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.

Authors:  C Pigeon; G Ilyin; B Courselaud; P Leroyer; B Turlin; P Brissot; O Loréal
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

4.  Molecular characterization of a case of atransferrinemia.

Authors:  E Beutler; T Gelbart; P Lee; R Trevino; M A Fernandez; V F Fairbanks
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

Review 5.  Iron regulatory proteins and the molecular control of mammalian iron metabolism.

Authors:  R S Eisenstein
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

6.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.

Authors:  Gaël Nicolas; Myriam Bennoun; Arlette Porteu; Sandrine Mativet; Carole Beaumont; Bernard Grandchamp; Mario Sirito; Michèle Sawadogo; Axel Kahn; Sophie Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

7.  HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions.

Authors:  Juxing Chen; Maja Chloupková; Junwei Gao; Tara L Chapman-Arvedson; Caroline A Enns
Journal:  J Biol Chem       Date:  2007-10-23       Impact factor: 5.157

8.  Regulation of iron absorption in Hfe mutant mice.

Authors:  Richard S Ajioka; Joanne E Levy; Nancy C Andrews; James P Kushner
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.

Authors:  David A Weinstein; Cindy N Roy; Mark D Fleming; Massimo F Loda; Joseph I Wolfsdorf; Nancy C Andrews
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

10.  Increased hepatic iron in mice lacking classical MHC class I molecules.

Authors:  Elsa M Cardoso; Maria G Macedo; Pierre Rohrlich; Eduarda Ribeiro; Manuel T Silva; François A Lemonnier; Maria de Sousa
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

View more
  139 in total

1.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 2.  Unraveling mechanisms regulating systemic iron homeostasis.

Authors:  Karin E Finberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 3.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 4.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 6.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

Review 7.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

Review 8.  Molecular mechanisms of normal iron homeostasis.

Authors:  An-Sheng Zhang; Caroline A Enns
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

9.  Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation.

Authors:  Ann-Kathrin Eisfeld; Rainer Krahl; Nadja Jaekel; Dietger Niederwieser; Haifa Kathrin Al-Ali
Journal:  Am J Blood Res       Date:  2012-11-25

10.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.